Prosecution Insights
Last updated: April 19, 2026

Codexis Inc.

5 pending office actions

Portfolio Summary

5
Total Pending OAs
2
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18247863 ENGINEERED GALACTOSE OXIDASE VARIANT ENZYMES VISONE, THOMAS J 1672 Non-Final OA Apr 04, 2023
18247054 ENGINEERED PANTOTHENATE KINASE VARIANT ENZYMES FRONDA, CHRISTIAN L 1652 Final Rejection Mar 28, 2023
18046893 RECOMBINANT REVERSE TRANSCRIPTASE VARIANTS LU, FRANK WEI MIN 1683 Non-Final OA Oct 14, 2022
17719321 METHODS AND SYSTEMS FOR ENGINEERING BIOMOLECULES HAYES, JONATHAN EDWARD 1685 Non-Final OA Apr 12, 2022
17761126 KETOREDUCTASE POLYPEPTIDES AND POLYNUCLEOTIDES MONDESI, ROBERT B 1652 Final Rejection Mar 16, 2022

Managing Codexis Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month